Ocean Biomedical, Inc. (OCEA) stock
OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)
Close on Oct 19, 2026Market cap $45.51KP/E –Yield –
Ocean Biomedical cash
Cash and short-term investments held at the end of each period.
Ocean Biomedical's cash was $800.00K at Mar 31, 2025. For fiscal 2024 it was $200.00K, up 4900.0% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $200.00K | +4900.0% |
| FY2023 | Dec 31, 2023 | $4.00K | -88.2% |
| FY2022 | Dec 31, 2022 | $34.00K | -96.8% |
| FY2021 | Dec 31, 2021 | $1.08M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | $800.00K | +4110.5% |
| Q4 FY2024 | Dec 31, 2024 | $200.00K | +4900.0% |
| Q3 FY2024 | Sep 30, 2024 | $200.00K | +545.2% |
| Q2 FY2024 | Jun 30, 2024 | $4.00K | -99.6% |
| Q1 FY2024 | Mar 31, 2024 | $19.00K | -93.8% |
| Q4 FY2023 | Dec 31, 2023 | $4.00K | -88.2% |
| Q3 FY2023 | Sep 30, 2023 | $31.00K | -93.4% |
| Q2 FY2023 | Jun 30, 2023 | $1.10M | +90.7% |
| Q1 FY2023 | Mar 31, 2023 | $306.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $34.00K | -96.8% |
| Q3 FY2022 | Sep 30, 2022 | $472.11K | – |
| Q2 FY2022 | Jun 30, 2022 | $576.76K | – |
| Q1 FY2022 | Mar 31, 2022 | $0 | – |
| Q4 FY2021 | Dec 31, 2021 | $1.08M | – |
| Q3 FY2021 | Sep 30, 2021 | $0 | – |
See a number that looks wrong?